Botanical Innovations has unlocked natures secrets to create new classes of phenolic rich Flavours, Fragrances & Ingredients for Functional Foods and Beverages, Nutraceutical and Cosmeceutical Applications.
Phenolic rich photo nutrients are the natural chemical compounds produced by plants from photosynthesis.
A plants phenolic compounds are divided into primary and secondary.
Primary Phenolic Compounds (metabolites)
Sugar
Fatty Acids
Amino Acids
Nucliec Acids
Secondary Phenolic Compounds (matabolites) are more complex and believed to be responsible for the plants respiratory systems and its ability to survive in the environment.
Antioxidants
Hyroxycinnamic Acids
Hydroxybenzoic Acids
Stilbenes
Flavonoids
Flavonols
Flavan-3-ols
A plant will produce compounds to adapt to changing environmental conditions such as flood, drought, heat, cold, nutritional distress and disease. In evolutionary terms phenols are believed to be responsible for plants migration from the sea to land when plants developed phenolic UV light screens and continued survival for millions of years.
Plants adapt to changing environmental conditions and stress by producing plant phenols which can produce free radicals and other oxidative compounds. Plants also have the ability to synthesise phenolic compounds which act as toxins and detergents to insects, pathogens and other dangers as well as assist with attraction of insects for reproduction purposes.
Botanical Innovations has created a unique set of phenolic rich flavours, fragrances & ingredients which contain concentrated phenolic compounds with unique properties developed by plants over millions of years.
Botanical Innovations Phenolic Rich Products
Plant Extracts
Fermented Plant Extract
Cold Pressed Seed Oils
Fermented Fruit & Vinegar
Fruit Powders
Essential Oils
Download Botanical Innovations Phenolic Compounds Report
Botanical Innovations Phenolic Compounds
Secondary Phenolic Compounds found in Botanical Innovations Products
Hydroxycinnamic Acids
Caffeic Acid
Name: Caffeic Acid
Chemical Composition: C9H8O4
Pharmacological Action
Antioxidants
P-Coumaric
Name: P-Coumaric
Chemical Composition: C9H8O3
Pharmacological Action
Antioxidants
Anti-Infective Agents
Free Radical Scavengers
Ferulic Acid
Name: Ferulic Acid
Chemical Composition: C10H10O4
Pharmacological Action
Anti-Inflammatory Agents, Non-
Steroidal
Cholagogues and Choleretics
Free Radical Scavengers
Anticoagulants
Antihypertensive Agents
Hydroxybenzoic Acids
Gallic Acid
Name: Gallic Acid
Chemical Composition: C7H6O5
Pharmacological Action
Antioxidants
Castalagin Vescalagin
Name: Castagin Vescalagin
Chemical Composition: C41H26O26
Pharmacological Action
Antioxidant
Tanin
Ellagic Acid
Name: Ellagic Acid
Chemical Composition: C14H6O8
Pharmacological Action
Antioxidant
Tannin
Benzaldehdye
Name: Benzaldehyde
Chemical Composition: C7H6O
Pharmacological Action
Flavouring, Perfume,
Pharmaceutical
Gentistate Acid
Name: Gentistate Acid
Chemical Composition: C7H6O4
Pharmacological Action
Antioxidants
Sallicylic Acid
Name: Sallicylic Acid
Chemical Composition: C7H6O3
Pharmacological Action
Anti-Infective Agents
Antifungal Agents
Keratolytic Agents
KEY PHARMACOLOGICAL ACTIVITY OF PHENOLIC COMPOUNDS IN BOTANICAL INNOVATIONS PRODUCTS
This information is a general guide only. For additional literature about the possible pharmacological activity of Botanical Innovations products please refer to our secondary literature review.
Antioxidants
Antioxidants inhibit or retard oxidation reactions. May counteract the damaging effects of oxidation in animal tissues.
Anti-Infective Agents
May prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Anti-coagulants
Agents that may assist in the prevention of blood clotting.
Free Radical Scavengers
May eliminate free radicals and among other effects, they may protect pancreatic islets against damage by cytokines and may prevent myocardial and pulmonary reperfusion injury.
Anti-Inflammatory Agents, Non- Steroidal
Anti-inflammatory agents that are nonsteroidal in nature. In addition to antinflammatory actions, they may have analgesic, antipyretic, and plateletinhibitory actions. They may act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Cholagogues and Choleretics
Gastrointestinal agents that may stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
Anti-hypertensive Agents
May assist in the management of used in the treatment vascular hypertension.
Anti-Infective Agents
Substances that may prevent infectious agents or organisms from spreading or may kill infectious agents in order to prevent the spread of infection.
Anti-fungal Agents
Substances may that destroy fungi by suppressing their ability to grow or reproduce. That is a potential defence against fungi present in human or animal tissues.
Keratolytic Agents
Agents that may soften, separate, and cause desquamation of the cornfield epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
Anti-carcinogenic Agents
Agents that may reduce the frequency or rate of spontaneous or induced tumours independently of the mechanism involved.
Anti-neoplastic Agents,
Phytogenic Agents obtained from higher plants that may have demonstrable cytostatic or antineoplastic activity.
Enzyme Inhibitors
Compounds or agents that may combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Platelet Aggregation Inhibitors
Drugs or agents, which may antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Anti-mutagenic Agents
Agents that may reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved.
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteas